Government of Tanzania   Report issue

Government Phase 1 Phase 3 Phase 4
Founded: Dodoma Tanzania, United Republic of (1961)

Organization Overview

First Clinical Trial
2005
NCT00152204
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dr. Nyanda Elias Ntinginya | Ministry of Health and Social Welfare, Tanzania | Ministry of Health, Tanzania | Mwanza Intervention Trials Unit, National Institute for Medical Research | National Malaria Control Programme, Tanzania | National Malaria Control Program, Tanzania | Pemba, Tanzania: Public Health Laboratory Ivo de Carneri | Tanzania Commission for Science and Technology | Tanzania Food and Drugs Authority | Tanzanian National Institute for Medical Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Ascariasis (Phase 4)

Ascaridiasis (Phase 4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 3)

Papilloma (Phase 3)

Trichuriasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 19